Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Nasser

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 28, 2020
Subspecialty training in Europe: a report by the European Network of Young Gynaecological OncologistsMaximilian Lanner, Tanja Nikolova, Bojana Gutic, et al.
Scientific Reports|December 23, 2016
Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced CancersMitesh J Borad, Jan B Egan, Rachel M Condjella, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 4, 2024
How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona MeetingJalid Sehouli, Jolijn Boer, Alison H Brand, et al.
Cancer Research|October 6, 2021
Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune EvasionSara A Byron, William P D Hendricks, Abhinav B Nagulapally, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona MeetingJalid Sehouli, Jolijn Boer, Alison H Brand, et al.
Plos One|April 7, 2021
Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trialPatricia M LoRusso, Aleksandar Sekulic, Jeffrey A Sosman, et al.
Plos Genetics|February 20, 2014
Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinomaMitesh J Borad, Mia D Champion, Jan B Egan, et al.
Nature Genetics|June 9, 2025
Author Correction: Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypesSheri Skerget, Daniel Penaherrera, Ajai Chari, et al.
Nature Genetics|August 19, 2024
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypesSheri Skerget, Daniel Penaherrera, Ajai Chari, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 28, 2020
Subspecialty training in Europe: a report by the European Network of Young Gynaecological OncologistsMaximilian Lanner, Tanja Nikolova, Bojana Gutic, et al.
Scientific Reports|December 23, 2016
Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced CancersMitesh J Borad, Jan B Egan, Rachel M Condjella, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 4, 2024
How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona MeetingJalid Sehouli, Jolijn Boer, Alison H Brand, et al.
Cancer Research|October 6, 2021
Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune EvasionSara A Byron, William P D Hendricks, Abhinav B Nagulapally, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
How to optimize and evaluate diversity in gynecologic cancer clinical trials: statements from the GCIG Barcelona MeetingJalid Sehouli, Jolijn Boer, Alison H Brand, et al.
Plos One|April 7, 2021
Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trialPatricia M LoRusso, Aleksandar Sekulic, Jeffrey A Sosman, et al.
Plos Genetics|February 20, 2014
Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinomaMitesh J Borad, Mia D Champion, Jan B Egan, et al.
Nature Genetics|June 9, 2025
Author Correction: Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypesSheri Skerget, Daniel Penaherrera, Ajai Chari, et al.
Nature Genetics|August 19, 2024
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypesSheri Skerget, Daniel Penaherrera, Ajai Chari, et al.
Pageof 6